The functional significance of microRNA-375 in human squamous cell carcinoma: Aberrant expression and effects on cancer pathways

Journal of Human Genetics

Volumn 57, Issue 9, 2012, Pages 556-563

  Kinoshita, Takashi ^a   Hanazawa, Toyoyuki ^a   Nohata, Nijiro ^a   Okamoto, Yoshitaka ^a   Seki, Naohiko ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

esophageal squamous cell carcinoma; head and neck squamous cell carcinoma; microRNA; miR 375

Indexed keywords

CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; EVEROLIMUS; GEFITINIB; JANUS KINASE 2; LACTATE DEHYDROGENASE; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA 1; MICRORNA 143; MICRORNA 375; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PROTEIN S6; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TEMSIROLIMUS;

3' UNTRANSLATED REGION; APOPTOSIS; BIOINFORMATICS; CANCER CELL; CANCER STAGING; CELL DIFFERENTIATION; CELL INVASION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CLONOGENESIS; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE OVEREXPRESSION; GENE SILENCING; GLUCOSE METABOLISM; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPERGLUCAGONEMIA; HYPERGLYCEMIA; HYPOPHARYNX CARCINOMA; INSULIN RELEASE; MAXILLA SINUS CARCINOMA; MOLECULAR CLONING; MOLECULARLY TARGETED THERAPY; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 84866851247     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2012.75     Document Type: Review

References (57)

1. Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer statistics. CA Cancer J. Clin. 60, 277-300 (2010).
2. Leemans, C. R., Braakhuis, B. J. & Brakenhoff, R. H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 11, 9-22 (2011).
3. Enzinger, P. C. & Mayer, R. J. Esophageal cancer. N. Engl. J. Med. 349, 2241-2252 (2003).
4. Akutsu, Y. & Matsubara, H. The significance of lymph node status as a prognostic factor for esophageal cancer. Surg. Today 41, 1190-1195 (2011).
5. Lagergren, J. & Lagergren, P. Oesophageal cancer. BMJ 341, c6280 (2010).
6. Mattick, J. S. RNA regulation: a new genetics? Nat. Rev. Genet. 5, 316-323 (2004).
7. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
8. Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9, 102-114 (2008).
9. Tran, N., O'Brien, C. J., Clark, J. & Rose, B. Potential role of micro-RNAs in head and neck tumorigenesis. Head Neck 32, 1099-1111 (2010).
10. Esquela-Kerscher, A. & Slack, F. J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer. 6, 259-269 (2006).
11. Ichimi, T., Enokida, H., Okuno, Y., Kunimoto, R., Chiyomaru, T., Kawamoto, K. et al. Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int. J. Cancer 125, 345-352 (2009).
12. Kano, M., Seki, N., Kikkawa, N., Fujimura, L., Hoshino, I., Akutsu, Y. et al. miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int. J. Cancer 127, 2804-2814 (2010).
13. Kikkawa, N., Hanazawa, T., Fujimura, L., Nohata, N., Suzuki, H., Chazono, H. et al. miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC). Br. J. Cancer 103, 877-884 (2010).
14. Moriya, Y., Nohata, N., Kinoshita, T., Mutallip, M., Okamoto, T., Yoshida, S. et al. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma. J. Hum. Genet. 57, 38-45 (2011).
15. Nohata, N., Hanazawa, T., Kikkawa, N., Sakurai, D., Fujimura, L., Chiyomaru, T. et al. Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinoma. Br. J. Cancer 105, 833-841 (2011).
16. Nohata, N., Hanazawa, T., Kikkawa, N., Mutallip, M., Sakurai, D., Fujimura, L. et al. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J. Hum. Genet. 56, 595-601 (2011).
17. Kinoshita, T., Nohata, N., Yoshino, H., Hanazawa, T., Kikkawa, N., Fujimura, L. et al. Tumor suppressive microRNA-375 regulates lactate dehydrogenase B in maxillary sinus squamous cell carcinoma. Int. J. Oncol. 40, 185-193 (2012).
18. Avissar, M., Christensen, B. C., Kelsey, K. T. & Marsit, C. J. MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin. Cancer Res. 15, 2850-2855 (2009).
19. Hui, A. B., Lenarduzzi, M., Krushel, T., Waldron, L., Pintilie, M., Shi, W. et al. Comprehensive microRNA profiling for head and neck squamous cell carcinomas. Clin. Cancer Res. 16, 1129-1139 (2010).
20. Lajer, C. B., Nielsen, F. C., Friis-Hansen, L., Norrild, B., Borup, R., Garnaes, E. et al. Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study. Br. J. Cancer 104, 830-840 (2011).
21. Wiklund, E. D., Gao, S., Hulf, T., Sibbritt, T., Nair, S., Costea, D. E. et al. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PLoS One 6, e27840 (2011).
22. Mathe, E. A., Nguyen, G. H., Bowman, E. D., Zhao, Y., Budhu, A., Schetter, A. J. et al. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin. Cancer Res. 15, 6192-6200 (2009).
23. Kong, K. L., Kwong, D. L., Chan, T. H., Law, S. Y., Chen, L., Li, Y. et al. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 61, 33-42 (2012).
24. Hui, A. B., Bruce, J. P., Alajez, N. M., Shi, W., Yue, S., Perez-Ordonez, B. et al. Significance of dysregulated metadherin and microRNA-375 in head and neck cancer. Clin. Cancer Res. 17, 7539-7550 (2011).
25. Li, X., Lin, R. & Li, J. Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig. Dis. Sci. 56, 2849-2856 (2011).
26. Tsukamoto, Y., Nakada, C., Noguchi, T., Tanigawa, M., Nguyen, L. T., Uchida, T. et al. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res. 70, 2339-2349 (2010).
27. Ding, L., Xu, Y., Zhang, W., Deng, Y., Si, M., Du, Y. et al. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res. 20, 784-793 (2010).
28. Basu, A., Alder, H., Khiyami, A., Leahy, P., Croce, C. M. & Haldar, S. MicroRNA-375 and microRNA-221: potential noncoding RNAs associated with antiproliferative activity of benzyl isothiocyanate in pancreatic cancer. Genes Cancer 2, 108-119 (2011).
29. Liu, A. M., Poon, R. T. & Luk, J. M. MicroRNA-375 targets hippo-signaling effector YAP in liver cancer and inhibits tumor properties. Biochem. Biophys. Res. Commun. 394, 623-627 (2010).
30. He, X.-X., Chang, Y., Meng, F.-Y., Wang, M.-Y., Xie, Q.-H., Tang, F. et al. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 31, 3357-3369 (2012).
31. Mazar, J., DeBlasio, D., Govindarajan, S. S., Zhang, S. & Perera, R. J. Epigenetic regulation of microRNA-375 and its role in melanoma development in humans. FEBS Lett 585, 2467-2476 (2011).
32. Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., Macdonald, P. E. et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432, 226-230 (2004).
33. Wienholds, E., Kloosterman, W. P., Miska, E., Alvarez-Saavedra, E., Berezikov, E., de Bruijn, E. et al. MicroRNA expression in zebrafish embryonic development. Science 309, 310-311 (2005).
34. El Ouaamari, A., Baroukh, N., Martens, G. A., Lebrun, P., Pipeleers, D. & van Obberghen, E. miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells. Diabetes 57, 2708-2717 (2008).
35. Poy, M. N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P. et al. miR- 375 maintains normal pancreatic alpha- and beta-cell mass. Proc. Natl Acad. Sci. USA 106, 5813-5818 (2009).
36. Ling, H. Y., Wen, G. B., Feng, S. D., Tuo, Q. H., Ou, H. S., Yao, C. H. et al. MicroRNA- 375 promotes 3T3-L1 adipocyte differentiation through modulation of extracellular signal-regulated kinase signalling. Clin. Exp. Pharmacol. Physiol. 38, 239-246 (2011).
37. Harris, T., Jimenez, L., Kawachi, N., Fan, J. B., Chen, J., Belbin, T. et al. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squamous cell carcinomas. Am. J. Pathol. 180, 917-928 (2012).
38. Komatsu, S., Ichikawa, D., Takeshita, H., Tsujiura, M., Morimura, R., Nagata, H. et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br. J. Cancer 105, 104-111 (2011).
39. Nishikawa, E., Osada, H., Okazaki, Y., Arima, C., Tomida, S., Tatematsu, Y. et al. miR- 375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancer. Cancer Res. 71, 6165-6173 (2011).
40. Giricz, O., Reynolds, P. A., Ramnauth, A., Liu, C., Wang, T., Stead, L. et al. Hsa-miR- 375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity. J. Pathol. 226, 108-119 (2012).
41. de Souza Rocha Simonini, P., Breiling, A., Gupta, N., Malekpour, M., Youns, M., Omranipour, R. et al. Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res. 70, 9175-9184 (2010).
42. Szczyrba, J., Nolte, E., Wach, S., Kremmer, E., Stohr, R., Hartmann, A. et al. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. Mol. Cancer Res. 9, 791-800 (2011).
43. Wang, F., Li, Y., Zhou, J., Xu, J., Peng, C., Ye, F. et al. miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am. J. Pathol. 179, 2580-2588 (2011).
44. Bhatti, I., Lee, A., James, V., Hall, R.I., Lund, J.N., Tufarelli, C. et al. Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. J. Gastrointest. Surg. 15, 199-208 (2011).
45. Ladeiro, Y., Couchy, G., Balabaud, C., Bioulac-Sage, P., Pelletier, L., Rebouissou, S. et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47, 1955-1963 (2008).
46. Wach, S., Nolte, E., Szczyrba, J., Stohr, R., Hartmann, A., Orntoft, T. et al. MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening. Int. J. Cancer 130, 611-621 (2012).
47. Selth, L. A., Townley, S., Gillis, J. L., Ochnik, A. M., Murti, K., Macfarlane, R. J. et al. Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease. Int. J. Cancer 131, 652-661 (2012).
48. Bryant, R. J., Pawlowski, T., Catto, J. W., Marsden, G., Vessella, R. L., Rhees, B. et al. Changes in circulating microRNA levels associated with prostate cancer. Br. J. Cancer 106, 768-774 (2012).
49. Carmona-Saez, P., Chagoyen, M., Tirado, F., Carazo, J. M. & Pascual-Montano, A. GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists. Genome Biol. 8, R3 (2007).
50. Nogales-Cadenas, R., Carmona-Saez, P., Vazquez, M., Vicente, C., Yang, X., Tirado, F. et al. GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res. 37, W317-W322 (2009).
51. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. & Tanabe, M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 40, D109-D114 (2012).
52. Grandis, J. R. & Tweardy, D. J. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53, 3579-3584 (1993).
53. Dassonville, O., Formento, J. L., Francoual, M., Ramaioli, A., Santini, J., Schneider, M. et al. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J. Clin. Oncol. 11, 1873-1878 (1993).
54. Maurizi, M., Almadori, G., Ferrandina, G., Distefano, M., Romanini, M. E., Cadoni, G. et al. Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br. J. Cancer 74, 1253-1257 (1996).
55. Amornphimoltham, P., Patel, V., Sodhi, A., Nikitakis, N. G., Sauk, J. J., Sausville, E. A. et al. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. Cancer Res. 65, 9953-9961 (2005).
56. Seshacharyulu, P., Ponnusamy, M. P., Haridas, D., Jain, M., Ganti, A. K. & Batra, S. K. Targeting the EGFR signaling pathway in cancer therapy. Expert Opin. Ther. Targets 16, 15-31 (2012).
57. Freudlsperger, C., Burnett, J. R., Friedman, J. A., Kannabiran, V. R., Chen, Z. & Van Waes, C. EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy. Expert Opin. Ther. Targets 15, 63-74 (2011).